Emergence of transferable daptomycin resistance in Gram-positive bacteria
Abstract Daptomycin (DAP) is a last-resort antibiotic to treat infections by multiresistant Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci. DAP resistance and clinical treatment failure has been associated with adaptive chro...
Saved in:
| Main Authors: | Tessa Marciniak, Lukas Kirchner, Silver A. Wolf, Birgit Walther, Thorsten Bischler, Justin Nyasinga, Revathi Gunturu, Torsten Semmler, Tom Gräfenhan, Andrew Whitelaw, Oliver Scherf-Clavel, Ulrike Holzgrabe, Wilma Ziebuhr |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Antimicrobials and Resistance |
| Online Access: | https://doi.org/10.1038/s44259-025-00109-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Daptomycin in treatment of Gram-positive infections in children with hematological disorders
by: Z. M. Dyshlevaya, et al.
Published: (2012-05-01) -
Understanding the selectivity in silico of colistin and daptomycin toward gram-negative and gram-positive bacteria, respectively, from the interaction with membrane phospholipids
by: Yesid Aristizabal, et al.
Published: (2025-07-01) -
Epidemiology and antibiotic resistance of staphylococci on commercial pig farms in Cape Town, South Africa
by: Remous Ocloo, et al.
Published: (2024-08-01) -
A Case of Daptomycin-Induced Eosinophilic Pneumonia
by: Neil Gerts, et al.
Published: (2023-02-01) -
Genetic Correlates of Synergy Mechanisms of Daptomycin Plus Fosfomycin in Daptomycin-Susceptible and -Resistant Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)
by: Warren E. Rose, et al.
Published: (2025-06-01)